Are Young Kindergarteners Over-diagnosed with ADHD?

Article

Results from two studies show that the youngest kids in a class are more likely to be diagnosed with ADHD than the oldest kids in their class.

The results of two studies, both scheduled for publication in the Journal of Health Economics, suggest that nearly 1 million children who have been diagnosed with ADHD might actually just young for their grade, adding evidence to support the idea of holding back children with Autumn birthdays (the cut-off in most states is September 1). The studies—led by researchers a Michigan State University (study 1) and multiple top universities (study 2), respectively—suggest that children who are the youngest in their kindergarten class are 60% more likely to receive an ADHD diagnosis than the oldest children in their class.

And the discrepancies don’t stop there; findings from study 1 show that the youngest among both fifth and eighth grade classes were more than twice as likely to use the ADHD drug Ritalin when compared with the oldest students in their classes. Although the agent certainly helps children with ADHD, it can cause unnecessary side effects—headaches, dizziness, and high blood pressure—in those who don’t truly have ADHD, according to study 2.

Todd Elder, Department of Economics, Michigan State University, and lead author of study 1, told USA Todaythat physicians should evaluate children for ADHD based on their age, not their grade, as there will always be kids in a given class who are a year older than others.

Noting the limitations of both studies, Elder cautioned that younger children may not be over-diagnosed with ADHD, as the study results would suggest. In fact, he said it’s possible that older children in a class might be under-diagnosed due to acting more maturely.

For More:

  • See what else Elder told USA Today
  • Read Elder’s article “The Importance of Relative Standards in ADHD Diagnoses: Evidence Based on Exact Birth Dates
  • Read the results of study 2, published in the Journal of Health Economics, “Measuring Inappropriate Medical Diagnosis and Treatment in Survey Data: The Case of ADHD among School-age Children
Recent Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
HCPLive Five at APA 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.